Show simple item record

dc.contributor.authorApkan, Mary
dc.contributor.authorAhmad, Raheelah
dc.contributor.authorShebl, Nada
dc.contributor.authorAshiru-Oredope, Diane
dc.date.accessioned2017-01-30T17:49:30Z
dc.date.available2017-01-30T17:49:30Z
dc.date.issued2016-01-13
dc.identifier.citationApkan , M , Ahmad , R , Shebl , N & Ashiru-Oredope , D 2016 , ' A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals ' , Antibiotics , vol. 5 , no. 5 , pp. 1-16 . https://doi.org/10.3390/antibiotics5010005
dc.identifier.otherPURE: 10503877
dc.identifier.otherPURE UUID: 4903bed2-4f38-460a-bef3-715514b134b3
dc.identifier.otherScopus: 85012874889
dc.identifier.urihttp://hdl.handle.net/2299/17582
dc.description© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). Mary Richard Akpan, Raheelah Ahmad, Nada Atef Shebl and Diane Ashiru-Oredope, 'A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals', Antibiotics, 2016, Vol 5(5). The version of record is available online at doi: doi:10.3390/antibiotics5010005
dc.description.abstractThe growing problem of antimicrobial resistance (AMR) has led to calls for antimicrobial stewardship programs (ASP) to control antibiotic use in healthcare settings. Key strategies include prospective audit with feedback and intervention, and formulary restriction and preauthorization. Education, guidelines, clinical pathways, de-escalation, and intravenous to oral conversion are also part of some programs. Impact and quality of ASP can be assessed using process or outcome measures. Outcome measures are categorized as microbiological, patient or financial outcomes. The objective of this review was to provide an overview of quality measures for assessing ASP and the reported impact of ASP in peer-reviewed studies, focusing particularly on patient outcomes. A literature search of papers published in English between 1990 and June 2015 was conducted in five databases using a combination of search terms. Primary studies of any design were included. A total of 63 studies were included in this review. Four studies defined quality metrics for evaluating ASP. Twenty-one studies assessed the impact of ASP on antimicrobial utilization and cost, 25 studies evaluated impact on resistance patterns and/or rate of Clostridium difficile infection (CDI). Thirteen studies assessed impact on patient outcomes including mortality, length of stay (LOS) and readmission rates. Six of these 13 studies reported non-significant difference in mortality between pre- and post-ASP intervention, and five reported reductions in mortality rate. On LOS, six studies reported shorter LOS post intervention; a significant reduction was reported in one of these studies. Of note, this latter study reported significantly (p < 0.001) higher unplanned readmissions related to infections post-ASP. Patient outcomes need to be a key component of ASP evaluation. The choice of metrics is influenced by data and resource availability. Controlling for confounders must be considered in the design of evaluation studies to adequately capture the impact of ASP and it is important for unintended consequences to be considered. This review provides a starting point toward compiling standard outcome metrics for assessing ASP.en
dc.format.extent16
dc.language.isoeng
dc.relation.ispartofAntibiotics
dc.rightsOpen
dc.subjectantimicrobial stewardship
dc.subjectantimicrobial resistance
dc.subjectquality indicators
dc.subjectoutcome
dc.subjectpatient
dc.subjectinfectious diseases
dc.titleA Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitalsen
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.relation.schoolSchool of Life and Medical Sciences
dc.description.versiontypeFinal Published version
dcterms.dateAccepted2016-01-13
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.3390/antibiotics5010005
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue
herts.rights.accesstypeOpen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record